Cervicore^TM Intervertebral Disc for the Treatment of Radicular Symptoms Associated with Loss of Disc Height, Disc/Osteophyte Complex or Herniated Disc of the Cervical Spine

The purpose of this study is to determine the safety and effectiveness of total disk replacement with the Cervicore^TM Artificial Disc. Patients are eligible for participation in this clinical trial if they are a candidate for a 1-level anterior cervical discectomy and fusion (ACDF) and meet the additional inclusion criteria and are void of any of the exclusion criteria. Patients who are enrolled in this clinical trial will undergo either an ACDF or placement of the Cervicore^TM Artificial Cervical Disc. Treatment is assigned randomly into 1 or 2 treatment arms.

You may be eligible to participate in this study if you:

• Are between the ages of 18-65
• Are a candidate for a 1-level ACDF
• Have neck and arm pain which has failed to improve with non-surgical treatment

You will be excluded from this study if you:

• Had previous neck surgery
• Have insulin-dependent diabetes, moderate to severe osteoporosis or severe arthritis requiring long-term steroid use
• Are unwilling or unable to return to Rush for the follow-up visits

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.